Delivery Order SPE2DB24D2010-SPE2DB24FZWX3

Award Date 8/12/24
Potential Completion Date 8/13/24
Potential Value $19K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $3,074.77 delivery order contract to Amerisourcebergen Drug Corp for the supply of ELIQUIS 5 MG TABLET 60S. The contract has a firm fixed price and an ultimate completion date of September 18, 2024. Amerisourcebergen, a major pharmaceutical distributor, has an Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with DLA Troop Support Medical for delivering a wide range of medical commodities to support military treatment programs....
The Defense Logistics Agency (DLA) has awarded a $11,180.96 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ELIQUIS 5 MG TABLET 60S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,900.08 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ELIQUIS 2.5 MG TABLET 60S. This delivery order is part of an Indefinite Delivery Contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to deliver pharmaceutical products and medical supplies in support of military treatment programs and facilities...
The U.S. Defense Logistics Agency (DLA) awarded a $9,388.10 firm fixed price delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, to provide ELIQUIS 5 MG TABLET 60S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025 between DLA Troop Support Medical and Amerisourcebergen, which enables the agency to efficiently procure a comprehensive range of medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,831.26 firm fixed-price delivery order is for the provision of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of May 15, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
The U.S. Defense Logistics Agency (DLA) awarded a $3,851.90 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4567732654 ELIQUIS 5 MG TABLET 60S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies...
The U.S. Defense Logistics Agency (DLA) has awarded a delivery order contract worth $10,213.18 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,564,287,343 ELIQUIS 5 MG TABLET 60S, with a performance period ending on April 16, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $47,865.60 firm-fixed-price delivery order is for the supply of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of January 27, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $13,072.56 Firm Fixed Price Delivery Order contract is for the supply of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of March 12, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
The U.S. Defense Logistics Agency (DLA) awarded a $3,448.04 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4557877886 - ELIQUIS 5 MG TABLET 60S. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) the company holds with DLA Troop Support Medical, which runs through November 2026. The IDC enables DLA to efficiently procure a comprehensive range of pharmaceutical products and medical...
  • SPE2DB24D2010
    Indefinite Delivery Contract
  • SPE2DB24D2010-SPE2DB24FZWX3
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $18,759.84 contract is for the supply of ELIQUIS 5 MG TABLET 60S, with a performance period through August 13, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 11/11/24, 9:25 AM